Michael CANNARILE,Carola RIES,Dominik RUETTINGER,Katharina WARTHA
申请号：
US15288431
公开号：
US20170247459A1
申请日:
2016.10.07
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to the combination therapy of antibodies binding to human CSF-1R, characterized in binding to the (dimerization) domains D4 to D5 (SEQ ID No: 85) of the extracellular domain of human CSF-1R in combination with a chemotherapeutic agent, radiation, and/or cancer immunotherapy.
